New Market Research
Report Added in MarketResearchReports.Biz Reports Database:
Cardiovascular Diseases Therapeutics Market in Asia-Pacific to 2019 -
Promising Pipeline Drugs to Offset Revenue Decline from Generic Erosion
and Off-Label Use
To check out the complete table of
contents, visit:
http://www.marketresearchreports.biz/analysis-details/cardiovascular-diseases-therapeutics-market-in-asia-pacific-to-2019-promising-pipeline-drugs-to-offset-revenue-decline-from-generic-erosion-and-off-label-use
Scope
- Disease overview and treatment usage patterns
- Market size and forecast for heart failure, MI and ACS in APAC market from 2012 to 2019
- Major marketed products for the indications types covered
- In-depth pipeline analysis for heart failure, MI and ACS
- Key drivers and restraints that have had and are expected to have a significant impact upon the market
- Key licensing and co-development agreements in the cardiovascular market
Reasons
to Buy
The
report will enhance your decision-making capability by allowing you to:
- Align your product portfolio to the markets with high growth potential
- Develop market entry and expansion strategies by identifying the potential regions and therapeutic segments poised for strong growth
- Devise a more effectively tailored country strategy through the understanding of key drivers and barriers in the cardiovascular market
- Develop key strategic initiatives based upon an understanding of key focus areas and leading companies
- Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships
Table
of Contents
1
Table of Contents
1.1
List of Tables
1.2
List of Figures
2
Introduction
3
Therapeutic Landscape
3.1
Heart Failure
3.1.1
Symptoms
3.1.2
Etiology
3.1.3
Pathophysiology
3.1.4
Co-morbidities and Complications
3.1.5
Diagnosis
3.1.6
Classification
3.1.7
Prognosis and Disease Staging
3.1.8
Treatment Options
3.2
Myocardial Infarction
3.2.1
Symptoms
3.2.2
Etiology
3.2.3
Pathophysiology
3.2.4
Co-morbidities and Complications
3.2.5
Diagnosis
3.2.6
Classification
3.2.7
Treatment Options
3.3
Acute Coronary Syndrome
3.3.1
Symptoms
3.3.2
Etiology
3.3.3
Pathophysiology
3.3.4
Diagnosis
3.3.5
Treatment Options
4
Marketed Products
4.1
Heart Failure
4.2
Myocardial Infarction
4.3
Acute Coronary Syndrome
4.4
Key Marketed Products
4.4.1
Arixtra (GlaxoSmithKline plc)
4.4.2
Brilinta (AstraZeneca plc)
4.4.3
Crestor (AstraZeneca plc)
4.4.4
Diovan (valsartan) and Diovan HCT/Co-Diovan (valsartan and hydrochlorothiazide)
4.4.5
Atacand (candesartan)
4.4.6
Lipitor (Atorvastatin Tablets)
4.4.7
Clopidogrel bisulfate
4.4.8
Angiomax (bivaluridin)
4.4.9
Lovenox (enoxaparin sodium injection)
4.4.10
Norvasc (amlodipine)
4.4.11
Coreg
4.4.12
Ivabradine (Les Laboratoires Servier SAS)
4.4.13
Toprol-XL
5
Pipeline Analysis
5.1
Heart Failure Pipeline
5.1.1
Overall Pipeline
5.1.2
Pipeline Analysis by Molecule Type
5.1.3
Pipeline Analysis by Mechanism of Action
5.2
Myocardial Infarction Pipeline
5.2.1
Overall Pipeline
5.2.2
Pipeline Analysis by Molecule Type
5.2.3
Pipeline Analysis by Mechanism of Action
About Us
MarketResearchReports.Biz is the most comprehensive
collection of market research reports. MarketResearchReports.Biz services are specially
designed to save time and money for our clients. We are a one stop solution for
all your research needs, our main offerings are syndicated research reports,
custom research, subscription access and consulting services. We serve all
sizes and types of companies spanning across various industries.
Contact
M/s
Sheela
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-618-1030
USA
– Canada Toll Free: 866-997-4948
No comments:
Post a Comment